J.H. Whitney Equity Partners VII, LLC, which maintains a ten percent ownership stake in Aveanna Healthcare Holdings, Inc., has formally reported the disposal of common stock valued at $36,455,577. This significant transaction was executed on June 3, 2026, marking a notable reduction in the private equity firm's direct exposure to the home healthcare provider. The sale involved the liquidation of 5,842,240 shares of Aveanna Healthcare common stock, which were divested at a uniform price of $6.24 per share.
The execution of this sale occurs against a backdrop of recent market volatility for Aveanna's equity. The stock was trading at $6.67 at the time of reporting, representing a 7.5% decline over the preceding week. Despite this short-term downward pressure, analytical frameworks suggest the stock may present a valuation opportunity. According to data from InvestingPro, AVAH remains positioned below its calculated Fair Value, a metric that has placed the ticker on the platform's list of Most Undervalued equities. Market observers note that stock price movements for AVAH have exhibited considerable volatility, with additional analytical tips available to subscribers for further context.
Following the completion of this divestment, J.H. Whitney Equity Partners VII, LLC, acting through its affiliate J.H. Whitney VII, L.P., retains a holding of 13,450,547 shares in Aveanna Healthcare. The broader corporate structure of the investment firm reveals additional layers of ownership. J.H. Whitney Equity Partners VII, LLC serves as the general partner for J.H. Whitney VII, L.P. and Whitney Strategic Partners VII, L.P. These entities, in turn, function as the managing members for PSA Healthcare Investment Holdings LLC and PSA Iliad Holdings LLC. Consequently, the firm's reported indirect holdings include 15,523,810 shares held by PSA Healthcare Investment Holdings LLC and 1,426,034 shares held by PSA Iliad Holdings LLC. The firm explicitly disclaims beneficial ownership of these securities, limiting its claim to the extent of its pecuniary interest.
While the equity divestment by J.H. Whitney highlights a change in institutional positioning, Aveanna Healthcare is simultaneously advancing its operational footprint through strategic acquisitions. The company recently finalized the acquisition of Family First Holding, LLC for a total consideration of $175.5 million in cash. Funded entirely from cash on hand, this transaction is designed to expand Aveanna's platform scale and strengthen its relationships with preferred payors. Family First Homecare, the target of the acquisition, operates 27 locations across seven states and specializes in providing skilled Private Duty Nursing services.
These operational developments have coincided with positive shifts in analyst sentiment and credit standing. RBC Capital recently upgraded Aveanna's stock rating from Sector Perform to Outperform. The firm cited solid execution regarding payor mix optimization and the ongoing expansion of the company's platform as key drivers for the upgrade. Concurrently, Moody's Ratings elevated Aveanna's corporate family rating from B3 to B2. This upgrade reflects improved business performance and a reduction in leverage, with the rating agency projecting that Aveanna will maintain its growth trajectory over the next 12 to 18 months.
In a move to further optimize its capital structure, Aveanna has announced a repricing of its credit facilities. This adjustment reduces interest rate margins by 50 basis points. The terms of this repricing include the potential for additional reductions contingent upon the achievement of specific credit ratings. These financial and operational maneuvers underscore a period of significant restructuring and expansion for the home healthcare provider, even as major institutional investors adjust their equity positions.